BNP Paribas Financial Markets’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $83.7M | Sell |
387,542
-83,526
| -18% | -$16M | 0.03% | 524 |
|
|
2026
Q1 | $86.4M | Sell |
471,068
-36,999
| -7% | -$6.82M | 0.04% | 454 |
|
|
2025
Q4 | $89.4M | Buy |
508,067
+112,129
| +28% | +$18.3M | 0.04% | 445 |
|
|
2025
Q3 | $55.5M | Buy |
395,938
+939
| +0.2% | +$127K | 0.03% | 588 |
|
|
2025
Q2 | $49.6M | Buy |
394,999
+28,818
| +8% | +$3.59M | 0.03% | 584 |
|
|
2025
Q1 | $50.1M | Sell |
366,181
-11,780
| -3% | -$1.68M | 0.03% | 599 |
|
|
2024
Q4 | $57.8M | Sell |
377,961
-35,399
| -9% | -$5.97M | 0.03% | 555 |
|
|
2024
Q3 | $80.1M | Buy |
413,360
+123,333
| +43% | +$25.8M | 0.05% | 341 |
|
|
2024
Q2 | $67.2M | Buy |
290,027
+8,626
| +3% | +$1.87M | 0.05% | 335 |
|
|
2024
Q1 | $60.7M | Buy |
281,401
+83,799
| +42% | +$19.6M | 0.05% | 371 |
|
|
2023
Q4 | $51.1M | Buy |
197,602
+34,081
| +21% | +$8.37M | 0.06% | 364 |
|
|
2023
Q3 | $42M | Buy |
163,521
+24,847
| +18% | +$6.65M | 0.05% | 346 |
|
|
2023
Q2 | $39.5M | Sell |
138,674
-79,975
| -37% | -$23.8M | 0.05% | 366 |
|
|
2023
Q1 | $60.8M | Sell |
218,649
-55,714
| -20% | -$15.4M | 0.09% | 243 |
|
|
2022
Q4 | $76M | Buy |
274,363
+53,760
| +24% | +$15.2M | 0.12% | 205 |
|
|
2022
Q3 | $58.9M | Buy |
220,603
+75,124
| +52% | +$16M | 0.09% | 237 |
|
|
2022
Q2 | $29.7M | Sell |
145,479
-25,038
| -15% | -$5.12M | 0.05% | 440 |
|
|
2022
Q1 | $35.9M | Buy |
170,517
+6,009
| +4% | +$1.31M | 0.05% | 390 |
|
|
2021
Q4 | $39.5M | Buy |
164,508
+66,348
| +68% | +$17.1M | 0.06% | 365 |
|
|
2021
Q3 | $27.8M | Sell |
98,160
-44,389
| -31% | -$14.5M | 0.04% | 477 |
|
|
2021
Q2 | $49.4M | Buy |
142,549
+27,597
| +24% | +$8.36M | 0.07% | 322 |
|
|
2021
Q1 | $32.2M | Buy |
114,952
+2,726
| +2% | +$735K | 0.05% | 392 |
|
|
2020
Q4 | $27.5M | Sell |
112,226
-61,825
| -36% | -$15.9M | 0.05% | 376 |
|
|
2020
Q3 | $49.4M | Sell |
174,051
-21,025
| -11% | -$5.86M | 0.07% | 273 |
|
|
2020
Q2 | $52.2M | Buy |
195,076
+58,864
| +43% | +$17.7M | 0.09% | 198 |
|
|
2020
Q1 | $43.1M | Sell |
136,212
-12,229
| -8% | -$3.71M | 0.09% | 214 |
|
|
2019
Q4 | $44M | Sell |
148,441
-306,629
| -67% | -$85.1M | 0.08% | 254 |
|
|
2019
Q3 | $106M | Buy |
455,070
+268,306
| +144% | +$62.5M | 0.19% | 113 |
|
|
2019
Q2 | $43.7M | Sell |
186,764
-101,530
| -35% | -$23.4M | 0.09% | 238 |
|
|
2019
Q1 | $68.1M | Buy |
288,294
+99,091
| +52% | +$31.2M | 0.15% | 152 |
|
|
2018
Q4 | $56.9M | Sell |
189,203
-36,730
| -16% | -$11.7M | 0.13% | 175 |
|
|
2018
Q3 | $79.8M | Buy |
225,933
+11,083
| +5% | +$3.82M | 0.12% | 174 |
|
|
2018
Q2 | $62.4M | Sell |
214,850
-140,147
| -39% | -$39.4M | 0.1% | 187 |
|
|
2018
Q1 | $97.2M | Buy |
354,997
+81,470
| +30% | +$25.3M | 0.18% | 103 |
|
|
2017
Q4 | $87.1M | Sell |
273,527
-64,931
| -19% | -$20.8M | 0.15% | 139 |
|
|
2017
Q3 | $106M | Buy |
338,458
+70,337
| +26% | +$20.8M | 0.26% | 76 |
|
|
2017
Q2 | $72.8M | Sell |
268,121
-58,390
| -18% | -$15.4M | 0.22% | 98 |
|
|
2017
Q1 | $89.3M | Buy |
326,511
+137,435
| +73% | +$38.9M | 0.24% | 92 |
|
|
2016
Q4 | $53.6M | Buy |
189,076
+36,817
| +24% | +$10.9M | 0.25% | 76 |
|
|
2016
Q3 | $47.7M | Buy |
152,259
+33,875
| +29% | +$10M | 0.2% | 93 |
|
|
2016
Q2 | $28.6M | Sell |
118,384
-151,290
| -56% | -$39.9M | 0.13% | 112 |
|
|
2016
Q1 | $70.2M | Buy |
269,674
+80,320
| +42% | +$21.2M | 0.3% | 62 |
|
|
2015
Q4 | $58M | Sell |
189,354
-83,273
| -31% | -$23.9M | 0.14% | 121 |
|
|
2015
Q3 | $79.6M | Buy |
272,627
+120,480
| +79% | +$39.8M | 0.2% | 71 |
|
|
2015
Q2 | $61.5M | Sell |
152,147
-83,586
| -35% | -$33.5M | 0.17% | 85 |
|
|
2015
Q1 | $99.5M | Sell |
235,733
-59,206
| -20% | -$23.3M | 0.28% | 58 |
|
|
2014
Q4 | $100M | Buy |
294,939
+49,646
| +20% | +$16.1M | 0.35% | 49 |
|
|
2014
Q3 | $81.1M | Buy |
245,293
+100,670
| +70% | +$33.2M | 0.07% | 145 |
|
|
2014
Q2 | $45.6M | Sell |
144,623
-109,219
| -43% | -$32.9M | 0.04% | 170 |
|
|
2014
Q1 | $72.9M | Sell |
253,842
-185,137
| -42% | -$58.8M | 0.06% | 141 |
|
|
2013
Q4 | $123M | Buy |
438,979
+5,571
| +1% | +$1.44M | 0.09% | 119 |
|
|
2013
Q3 | $104M | Buy |
433,408
+245,327
| +130% | +$54.9M | 0.08% | 140 |
|
|
2013
Q2 | $40.5M | Buy |
+188,081
| New | +$40.2M | 0.03% | 175 |
|
Other funds holding BIIB
VCM
VPM
BNP Paribas Financial Markets's BIIB Position: Q2 2026 in Review
BNP Paribas Financial Markets reduced its Biogen (BIIB) stake by 18% in Q2 2026, selling an estimated $16M and leaving 387,542 shares worth $83.7M. The position accounts for 0.03% of the portfolio, ranked #524.
BNP Paribas Financial Markets first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $123M in Q4 2013. 842 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- BNP Paribas Financial Markets held 387,542 shares of Biogen worth $83.7M as of Q2 2026.
- BNP Paribas Financial Markets sold 83,526 Biogen shares in Q2 2026, an estimated $16M.
- Biogen made up 0.03% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #524 holding.
- BNP Paribas Financial Markets first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- BNP Paribas Financial Markets's Biogen position peaked at $123M in Q4 2013.
- 842 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.